Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maze Therapeutics (MAZE) Assets Average (2025 - 2026)

Maze Therapeutics' Assets Average history spans 2 years, with the latest figure at $408.4 million for Q1 2026.

  • On a quarterly basis, Assets Average rose 42.46% to $408.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $408.4 million, a 42.46% increase, with the full-year FY2025 number at $318.8 million, changed N/A from a year prior.
  • Assets Average hit $408.4 million in Q1 2026 for Maze Therapeutics, roughly flat from $409.6 million in the prior quarter.
  • Over the last five years, Assets Average for MAZE hit a ceiling of $409.6 million in Q4 2025 and a floor of $286.7 million in Q1 2025.